Uncover key drivers, emerging technologies, and competitive movements shaping the endoscopic retrograde cholangiopancreatography (ercp) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market in 2026, and what figure is it projected to hit by 2030?

The endoscopic retrograde cholangiopancreatography (ercp) market size has experienced substantial expansion in recent years. Its value is projected to rise from $1.86 billion in 2025 to $2.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. The market’s past growth is attributable to factors such as the prevalence of gallstones, an aging population, the burden of gastrointestinal diseases, the expansion of hospital endoscopy services, and the adoption of imaging-guided procedures.

The endoscopic retrograde cholangiopancreatography (ercp) market is projected for substantial expansion in the coming years. It is set to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This anticipated growth is attributable to factors such as advanced endoscopic training, improved early pancreatic diagnosis, an increase in therapeutic procedures, enhancements in hospital infrastructure, and the rising demand for minimally invasive care. Key trends shaping this period encompass the increasing prevalence of biliary disorders, a greater adoption of therapeutic endoscopy, the expansion of minimally invasive GI procedures, the establishment of more advanced endoscopy units, and an emphasis on the prompt diagnosis of pancreatic diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

Which Drivers Are Affecting Market Participation In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

The rising occurrence of gastrointestinal ailments is anticipated to drive the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market in the coming period. These conditions encompass a wide array of illnesses or diseases impacting the gastrointestinal (GI) tract, comprising the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, and anus, along with vital accessory organs such as the liver, gallbladder, and pancreas. The growing incidence of gastrointestinal conditions can be ascribed to multiple elements, including shifts in diet, an aging demographic, the use of antibiotics, various lifestyle choices, and environmental impacts. ERCP assists in treating individuals suffering from gastrointestinal conditions by offering a less invasive procedure for diagnosing and addressing problems in the bile and pancreatic ducts, including gallstones, constrictions, growths, or infections. A specific example is that in January 2024, the American Cancer Society, a non-profit organization based in the US, projected approximately 26,890 new instances of stomach cancer in the United States, with an estimated 10,880 fatalities from this specific cancer. Consequently, the increasing prevalence of gastrointestinal conditions is fueling the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market.

What Segment Categories Are Covered In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

The endoscopic retrograde cholangiopancreatography (ercp) market covered in this report is segmented –

1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

2) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

What Trends Are Projected To Support The Growth Of The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

Major entities operating within the ERCP market are prioritizing the creation of innovative technologies, notably the cholangioscope direct visualisation system, to facilitate advanced, high-resolution visual inspection of the bile and pancreatic ducts. This particular medical device enables enhanced, high-definition imaging of these ducts during ERCP procedures. An example of this innovation occurred in July 2024, when Penlon Limited, a UK-based medical device company, launched its VedVision Cholangioscope Direct Visualisation System. This advanced system is specifically engineered for high-resolution, direct visualization of the bile and pancreatic ducts, thereby improving both diagnostic capabilities and therapeutic interventions during ERCP procedures. Its design includes a 2 mm accessory channel and a dedicated guidewire channel for secure access, along with a comprehensive suite of accessories like biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.

Which Leading Companies Dominate The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Share?

Major companies operating in the endoscopic retrograde cholangiopancreatography (ercp) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ercp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20770&type=smp

Browse Through More Reports Similar to the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market 2026, By The Business Research Company

Capsule Endoscopy System Market Report 2026

https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report

Endoscopic Ultrasound Market Report 2026

https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report

Primary Biliary Cholangitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model